What is Coronavirus?
Coronaviruses are a large family of viruses, which cause illnesses going from a simple cold (some seasonal viruses are Coronaviruses) to more severe pathologies such as MERS-COV or SARS. The virus identified in January 2020 in China is a new Coronavirus. The disease caused by this Coronavirus has been named COVID-19 by the World Health Organization – WHO. Since March 11, 2020, WHO has described the global situation of
COVID-19 as a pandemic; that is, the epidemic now affects 110 countries over a large area.
What are the symptoms of COVID-19 ?
The main symptoms are fever or feeling of fever and signs of breathing difficulties, such as coughing or shortness of breath.
Is there a vaccine?
There is no vaccine for the COVID-19 Coronavirus at this time. Several treatments are being evaluated in France, in conjunction with the WHO, to be used against the COVID-19 Coronavirus. In the meantime, treatment is symptomatic.
How is COVID-19 Coronavirus transmitted?
The disease is transmitted by postillions (sneezing, coughing). It is therefore considered that close contact with a sick person is necessary to transmit the disease: same place of life, direct contact within a meter during a cough, sneeze or a discussion in the absence of protective measures. One of the preferred vectors for the transmission of the virus is contact with unwashed hands.
* Source: Ministry of Health, see link here.
What are the instructions for health establishments?
The COVID-19 methodological guide for the Epidemic risk of the Ministry of Health for health establishments in France recommends clear measures on air hygiene:
- Rooms allowing isolation of patients (single room, with correct air renewal without recycling within the establishment)
- The day hospital sector must have at least one room with suitable air treatment, negative pressure is not compulsory.
Source: Ministry of Health, February 20, 2020. See link here.
How can ATA help ?
The new coronavirus (COVID-19) is part of the Coronaviridae family, made up of a lipid membrane of cellular origin. We tested our F7 + H14 filtration chain and photocatalysis decontamination technologies, and Bioxygen® module on the H1N1 Influenza virus, from the lipid membrane category, like that of coronaviridae, we obtained 99.9929{01e3c5e93231d16e008ef94f2b1d6fd0127ff363a7cc717001d1444d838f865e} retention (Virnext test report result: ATA20140305E5 Lyon, 03/05/14)
VirNext is a technological service and innovation platform whose objectives are to meet the scientific and technological needs of industrialists in Virology / Microbiology. VirNext specializes in the evaluation of physical, chemical and biological technologies for decontaminating indoor air and surfaces, as well as technologies for cleaning up / disinfecting water and effluents.
VirNext has set up experimental procedures to assess the effectiveness of the Room Dopair / Dopair filtration system in decontaminating a confined space contaminated with viruses of the same category of coronaviridae.
Conclusion after study: The « Room Dopair / Dopair » system developed by the company ATA-Medical makes it possible to decontaminate a confined space of 2.5 m3 in 5 minutes associated with efficiencies of 99.9929{01e3c5e93231d16e008ef94f2b1d6fd0127ff363a7cc717001d1444d838f865e} and 99.905{01e3c5e93231d16e008ef94f2b1d6fd0127ff363a7cc717001d1444d838f865e} respectively for the categories of viruses with lipid membranes such as coronaviridae, and without membranes such as Adenovirus type 5, respectively. The « Room Dopair / Dopair » system therefore makes it possible to decontaminate the air in a confined space containing viruses such as COVID-19.
The complete test result is available on request, contact us here
